Evidence map›Paper›PMID 15088269›Full record

ArticleAmerican journal of human genetics2004

Methods for high-density admixture mapping of disease genes.

Nick Patterson, Neil Hattangadi, Barton Lane, Kirk E Lohmueller, David A Hafler, Jorge R Oksenberg, Stephen L Hauser, Michael W Smith, Stephen J O'Brien, David Altshuler and 2 more

2 registry-linked trialsAbstract read
In one paragraph

Article in American journal of human genetics, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 307 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
307citing papers in PubMed, 8 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00344136 completednot on this map

Health Disparities and CVD: Admixture Mapping in the Jackson Heart Study

TypeobservationalSponsorNational Heart, Lung, and Blood Institute (NHLBI)Ran2000 to 2004Enrolled5,302ConditionsHeart Diseases
NCT00559767 completednot on this mapstarted 2006, after this paper: background citation

Mapping of End Stage Renal Disease Genetic Susceptibility in African Americans by Admixture Linkage Disequilibrium

TypeobservationalSponsorNational Cancer Institute (NCI)Ran2006 to 2012Enrolled2,860ConditionsEnd Stage Renal Disease (ESRD)
3 · Its place in the literature

Who cites it

307 citing papers in PubMed, 8 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Trial
  10. Examination of Potential Modifiers of the Association of APOL1 Alleles with CKD Progression.Clinical journal of the American Society of Nephrology : CJASN · 2015
    Trial
  11. Trial
  12. Trial
  13. Article
  14. Article
  15. Observational
  16. Admixture Mapping of Lipid Traits in Hispanic Americans.Journal of the American Heart Association · 2025
    Article
  17. Article
  18. Article
  19. Article
  20. Article

247 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Nick PattersonProgram in Medical and Population Genetics, Broad Institute, Cambridge, MA, USA.
Neil Hattangadi
Barton Lane
Kirk E Lohmueller
David A Hafler
Jorge R Oksenberg
Stephen L Hauser
Michael W Smith
Stephen J O'Brien
David Altshuler
Mark J Daly
David Reich

Funding

Virginia Mason/UCHSC Autoimmune Prevention CenterU19AI050864 · NIAID · UNIVERSITY OF COLORADO DENVER · PI EISENBARTH, GEORGE S · 2001 to 2011
$29.2M
Statistics and Genomics - a work programK01HG002758 · NHGRI · WHITEHEAD INSTITUTE FOR BIOMEDICAL RES · PI PATTERSON, NICK J · 2003 to 2007
$825k
NHGRI NIH HHS K01 HG002758NHGRI NIH HHS K-01 HG002758-01NIAID NIH HHS U19 AI050864NIAID NIH HHS U19 AI50864Wellcome Trust
6 · The paper itself

Abstract

Admixture mapping (also known as "mapping by admixture linkage disequilibrium," or MALD) has been proposed as an efficient approach to localizing disease-causing variants that differ in frequency (because of either drift or selection) between two historically separated populations. Near a disease gene, patient populations descended from the recent mixing of two or more ethnic groups should have an increased probability of inheriting the alleles derived from the ethnic group that carries more disease-susceptibility alleles. The central attraction of admixture mapping is that, since gene flow has occurred recently in modern populations (e.g., in African and Hispanic Americans in the past 20 generations), it is expected that admixture-generated linkage disequilibrium should extend for many centimorgans. High-resolution marker sets are now becoming available to test this approach, but progress will require (a). computational methods to infer ancestral origin at each point in the genome and (b). empirical characterization of the general properties of linkage disequilibrium due to admixture. Here we describe statistical methods to estimate the ancestral origin of a locus on the basis of the composite genotypes of linked markers, and we show that this approach accurately estimates states of ancestral origin along the genome. We apply this approach to show that strong admixture linkage disequilibrium extends, on average, for 17 cM in African Americans. Finally, we present power calculations under varying models of disease risk, sample size, and proportions of ancestry. Studying approximately 2500 markers in approximately 2500 patients should provide power to detect many regions contributing to common disease. A particularly important result is that the power of an admixture mapping study to detect a locus will be nearly the same for a wide range of mixture scenarios: the mixture proportion should be 10%-90% from both ancestral populations.

Indexed as

AllelesBlack or African AmericanBlack PeopleChromosome MappingEthnicityGene FrequencyGenetic Diseases, InbornGenetic MarkersGenome, HumanHumansLinkage DisequilibriumPolymorphism, GeneticRiskSoftwareTandem Repeat SequencesWhite PeopleGenetic Markers

Identifiers

PMID15088269
PMCPMC1181990

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.